tiprankstipranks
Adicet Bio (GB:0HX7)
LSE:0HX7

Adicet Bio (0HX7) Ownership - Who Owns Adicet Bio?

0 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 26, 2024
Carl Gordon
Director, >10% Owner
Bought$7500000
Jan 26, 2024
Orbimed Advisors Llc
Director, >10% Owner
Bought$7500000
Oct 02, 2023
Chen Schor
President & Ceo,director
Sold$47085
Oct 02, 2023
Chen Schor
President & Ceo,director
Bought$15125

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$28217

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,028,048Institution3.69%6,404,322
1,835,091Institution2.23%3,881,217
152,282Institution0.19%322,076
120,443Institution0.15%254,737
66,687Institution0.08%141,043
41,608Institution0.05%88,001
41,367Institution0.05%87,491
14,930Institution0.02%31,577
11,423Institution0.01%24,160
8,878Institution0.01%18,777

Top Mutual Fund Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Adicet Bio (GB:0HX7)?
Currently, no data Available
What percentage of Adicet Bio (GB:0HX7) stock is held by institutional investors?
Currently, no data Available
What percentage of Adicet Bio (GB:0HX7) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Adicet Bio (GB:0HX7)?
Vanguard owns the most shares of Adicet Bio (GB:0HX7).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis